When the tax year ends on the 5th of April, valuable tax allowances may be lost simply because people left things too late.

Thankfully, Vanguard is here to help you make well-consider decisions, not rushed ones.

Their tax year-end hub is full of clear guidance, helpful tools and timely reminders to help you understand your allowances and give your investments

the best chance to grow. Search Vanguard investor to learn more. When investing, your capital is at risk.

Tax rules apply.

Here's your midday brief for Wednesday, March 25th. I'm Alex Osala for the Wall Street Journal.

Iran has dismissed the Trump administration's 15-point plan to end the war and says it amounts to a wishlist of objectives that haven't been achieved militarily.

Iran set out its own conditions for a ceasefire via a state broadcaster, including an end to a tax by the U.S. and

Israel, financial compensation for damages caused by the conflict and sovereignty over the

Strait of Hormuz.

President Trump has installed some of the biggest names in business to a technology

counsel to weigh in on AI policy and other issues.

Some of those names include META CEO Mark Zuckerberg, Oracle Executive

Chairman Larry Ellison, and NVIDIA CEO Jensen Wong. And Merck has agreed to a nearly

$6 billion cash deal to acquire the California biotech firm turns pharmaceutical to gain

access to a promising experimental pill for chronic myeloid leukemia.

Merck's top-selling drug, Ketruda, is losing patent protection in 2028,

which could mean a big chunk of lost revenue for Merck.

Analysts say the new leukemia treatment could become a blockbuster,

with more than $2 billion in annual sales.

Heads up, an artificial intelligence tool helped us make this episode by creating summaries

that were based on WSJ reporting and then reviewed and adapted by an editor.

...